Cytokinetics (CYTK) Misses Q4 EPS by 42c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 62.20 -0.11 (0.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.31 | 52 Week High | $13.18 | |||
| Open | $64.06 | 52 Week Low | $6.00 | |||
| Day High | $64.06 | P/E | N/A | |||
| Day Low | $62.14 | EPS | $-1.24 | |||
| Volume | 43,310 | |||||
